Status:
COMPLETED
Dynamic Evaluation of COVID-19 Diagnostic Tests
Lead Sponsor:
Tourcoing Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rapid antigenic tests are not yet used in real life. Their contribution in the diagnostic strategy based on the gold standard including anamnesis, thoracic CT and PCR has not been evaluated. We propo...
Detailed Description
This is an interventional study comparing gold standard anamnesis, thoracic CT and PCR versus SARS-Cov-2 antigen, anamnesis and thoracic CT for the diagnosis of COVID-19 infection. Patients will be s...
Eligibility Criteria
Inclusion
- Symptomatic patient with confirmed Gold-Standard SARS-CoV-2 (COVID-19) infection
- Presenting at least one criterion for hospitalization:
- Respiratory failure and oxygenation
- Circulatory failure (systolic BP \< 90 mmHg)
- Neurological failure (confusion, drowsiness, altered consciousness)
- Polypathological terrain and co-morbidities (chronic respiratory failure, heart failure or cardiovascular pathology, renal failure, diabetes, immunosuppression, obesity, cirrhosis)
- Eligible for different sampling methods
- Beneficiary of a social insurance scheme or entitled person
Exclusion
- Gold Standard not in favour of SARS-Cov-2 infection (COVID 19)
- Minor patient
- Refusal to participate
- Patient under guardianship
- Patient under guardianship
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 13 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04337996
Start Date
July 13 2020
End Date
January 13 2021
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Tourcoing
Tourcoing, France, 59208